Preventing next Pandemic
Movers And Shakers
Kepler Diagnostics, Inc. is a leading provider of cutting-edge remote diagnostics technologies, offering scalable solutions for bodily sample collection of all types. Founded by industry veterans who started by scribbling their ideas on a piece of paper, today we developed Samplla, the first dry specimen collection devices that enables sensitive tests preservation, including RNA viruses in blood, bacterial DNA in urine, monoclonal therapeutic antibodies and enzymes - the toughest tests to stabilized. Get in touch today to learn more.
What We Do
Testing is key
Since Covid-19 major global epidemics became worse. Hepatitis C infections increased dramatically due to decrease testing and therefore treatment. Chronic liver diseases increased due to increase in alcohol consumption. In parallel, extremely severe anemia increased due to increase cost of food and supply bottlenecks —Worsening patients' condition world wide.
At Kepler Diagnostics, we believe that testing is key and our Samplla solutions will soon become one of the biggest segments in the industry. We’ve only just started, but we already know that every product we build requires hard-earned skills, dedication and a daring attitude. Continue reading and learn all there is to know about the smart tech behind our successful Technology Company.
"The higher we are placed, the more humbly we should walk"